We compared the levels of active GSK3β in primary fibroblasts from the same patients used to examine GSK3β levels in PBMC samples vs. controls and found the same trend showing an increase in active GSK3β in DM1 fibroblasts (Figure 5E). The gene discussed is GSK3B; the disease is myotonic dystrophy type 1.